บทฟื้นฟูทางวิชาการเรื่องการรักษาด้วยรังสีรักษา สำหรับผู้ป่วยมะเร็งกล่องเสียง
Abstract
This article will review the role of radiation therapy for cancer of the glottic larynx in both early and locally advanced stages. For early stage disease, radiation therapy plays a major role as a laryngeal preservation treatment with a recommended dose of higher than 2 Gy per fraction or using a hyperfractionation schedule. For locally advanced disease, treatments options are radiation therapy in combination with chemotherapy or targeted therapy, radiotherapy alone with alterfractionation scheme, alterfraction radiation treatment with concurrent chemotherapy or total laryngectomy followed by postoperative radiation therapy with /without chemotherapy
References
Jones AS, Fish B, Fenton JE et al. The treatment of early laryngeal cancer (T1-T2, N0): Surgery or irradiation? Head and neck 2004; 127-35.
Mendenhall WM, Amdur RJ, Morris CG, et al. T1-T2 N0 Squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol 2001; 19: 4029-36.
Yamazaki H, Nishiyama K, Tanaka E, et al. Radiotherapy for early glottic carcinoma (T1N0M0): Result of prospective randomized study of radiation fraction size and overall treatment time. Int J Radiat Biol Phys 2006; 64: 77-82.
Yu E, Shenouda G, Beaudet MP, et al. Impact of radiation therapy fraction size on local control of early glottis carcinoma. Int J Radiat Biol Phys 1997; 37(3): 587-91.
Kok G. Influence of the size of the fraction dose on normal and tumor tissue in 60 Co radiation treatment of carcinoma of the larynx and inoperable carcinoma of the breast. Radiol Clin Biol 1971; 40:100-15.
Garden AS, Morrison WH, Ang KK. Larynx and hypopharynx cancer. In Gunderson LL, Tepper JE. editor. Clinical radiation oncology 2nd ed. Philadelphia: Churchill Livingstone ; 2007.p.727-754.
Garden AS, Foster K, Wong PF, et al. Result of radiation therapy for T2N0 glottic carcinoma: Does the '2' stand for twice daily treatment?. Int J Radiat Oncol Biol Phys 2003; 55: 322-28.
Mendenhall WM, Amdur RJ, Morris CG, et al. T1-T2 N0 Squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol 2001; 19: 4029-36.
Wolf GT, Hong WK, Fisher HG, et al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991; 324: 1685-90.
Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003; 349: 291-8.
Urba S, Wolf G, Eisbruch A, et al. Single cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation : A new treatment paradigm. J Clin Oncol 2006; 24: 593-8.
Fu KK, Pajak TF, Trotti A, et al. A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell
carcinomas : First report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000; 48: 7-16.
Overgaard J, Hansen HS, Specht L, et al. Five compared with six fractions per week of conventional radiotherapy of squamous cell carcinoma of head and neck : DAHANCA 6&7 randomized controlled trial. Lancet 2003; 362: 933-42.
Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated radiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998; 338: 1798-804.
Bonner JA, Harari PM, Giralt J. Radiotherapy plus Cetuximab for squamous cell carcinoma of the head and neck. N Engl J Med 2006; 354: 567-78.
Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high risk squamous cell carcinoma of the head and neck. N Engl J Med 2004; 350: 1937-44.
Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004; 350: 1945-52.
Bernier J, Cooper JS, Pajak TF, et al. Defining risk levels in locally advanced head and neck cancers; a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of EORTC(#22931) and RTOG (#9501). Head Neck 2005; 27:
843-50.
Downloads
Published
How to Cite
Issue
Section
License
บทความที่ได้รับการตีพิมพ์เป็นลิขสิทธิ์ของวารสารมะเร็งวิวัฒน์ ข้อความที่ปรากฏในบทความแต่ละเรื่องในวารสารวิชาการเล่มนี้เป็นความคิดเห็นส่วนตัวของผู้เขียนแต่ละท่านไม่เกี่ยวข้องกับ และบุคคลากรท่านอื่น ๆ ใน สมาคมฯ แต่อย่างใด ความรับผิดชอบองค์ประกอบทั้งหมดของบทความแต่ละเรื่องเป็นของผู้เขียนแต่ละท่าน หากมีความผิดพลาดใดๆ ผู้เขียนแต่ละท่านจะรับผิดชอบบทความของตนเองแต่ผู้เดียว
